A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 7, 2018

Primary Completion Date

August 22, 2018

Study Completion Date

August 22, 2018

Conditions

Cystic Fibrosis

Interventions

DRUG

FDL176 & FDL169 coadministration

CFTR corrector and potentiator

Trial Locations (1)

Quotient Sciences, Nottingham

All Listed Sponsors

lead

Flatley Discovery Lab LLC

OTHER

NCT03516331 - A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects | Biotech Hunter | Biotech Hunter